Publications by authors named "Rekha Jonnalagedda"

Article Synopsis
  • This phase 3 study evaluated the safety and effectiveness of the MenACWY-CRM vaccine, aiming for approval in India, involving 180 healthy participants aged 2-75 years.
  • Participants received one dose of the vaccine, and immune responses were measured before and after vaccination; adverse events were also monitored throughout the study period.
  • Results showed a strong immune response in all age groups, with high percentages achieving protective levels against the four serogroups, and the vaccine was reported to be well tolerated with no major safety issues.
View Article and Find Full Text PDF

Despite availability of effective rabies vaccines, India has the highest global mortality rate for rabies. Low socio-economic communities are most affected due to lack of awareness of the disease and poor compliance to post-exposure prophylactic regimens. Currently, the only approved intramuscular regimen for post-exposure prophylaxis (PEP) against rabies in India is the Essen regimen, which consists of 5 injections administered over 5 separate days in a period of one month.

View Article and Find Full Text PDF